anlotinib,tiragolumab,ociperlimab,cabozantinib
roche,exelixis,sino biopharma,beigene,advenchen
[]
future for escc . #ascogi23 #gi23 
Oncology care , to give or not to give chemo , data analysis , oncology pharamocovigilance , enthusiastic critic, twitts are not twists